{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:53:57Z","timestamp":1649166837699},"reference-count":4,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2021,12,10]]},"DOI":"10.1253\/circrep.cr-21-0141","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T22:08:42Z","timestamp":1636582122000},"page":"749-750","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis\u3000\u2015 Reply \u2015"],"prefix":"10.1253","volume":"3","author":[{"given":"Yuri","family":"Ochi","sequence":"first","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kitaoka","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ochi Y, Kubo T, Baba Y, Sugiura K, Ueda M, Miyagawa K, et al. Wild-type transthyretin amyloidosis in female patients: Consideration of sex differences. <i>Circ Rep<\/i> 2021; 3: 465\u2013471.","DOI":"10.1253\/circrep.CR-21-0067"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T, et al; on behalf of the Japanese Circulation Society Joint Working Group. JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. <i>Circ J<\/i> 2020; 84: 1610\u20131671.","DOI":"10.1253\/circj.CJ-20-0110"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Endo J, Sano M, Izumiya Y, Tsujita K, Nakamura K, Tahara N, et al. A statement on the appropriate administration of tafamidis in patients with transthyretin cardiac amyloidosis. <i>Circ J<\/i> 2019; 84: 15\u201317.","DOI":"10.1253\/circj.CJ-19-0811"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Aimo A, Vergaro G, Castiglione V, Rapezzi C, Emdin M. Safety and tolerability of neurohormonal antagonism in cardiac amyloidosis. <i>Eur J Intern Med<\/i> 2020; 80: 66\u201372.","DOI":"10.1016\/j.ejim.2020.05.015"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/3\/12\/3_CR-21-0141\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T03:35:18Z","timestamp":1639193718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/3\/12\/3_CR-21-0141\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":4,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-21-0141","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,10]]},"article-number":"CR-21-0141"}}